BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE and INCORRECT DOSE ADMINISTERED BY DEVICE

732 reports of this reaction

3.2% of all BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE reports

#7 most reported adverse reaction

Overview

INCORRECT DOSE ADMINISTERED BY DEVICE is the #7 most commonly reported adverse reaction for BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, manufactured by AstraZeneca Pharmaceuticals LP. There are 732 FDA adverse event reports linking BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE to INCORRECT DOSE ADMINISTERED BY DEVICE. This represents approximately 3.2% of all 23,211 adverse event reports for this drug.

Patients taking BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE who experience incorrect dose administered by device should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

INCORRECT DOSE ADMINISTERED BY DEVICE732 of 23,211 reports

INCORRECT DOSE ADMINISTERED BY DEVICE is moderately reported among BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE users, representing a notable but not dominant share of adverse events.

Other Side Effects of BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE

In addition to incorrect dose administered by device, the following adverse reactions have been reported for BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE:

Other Drugs Associated with INCORRECT DOSE ADMINISTERED BY DEVICE

The following drugs have also been linked to incorrect dose administered by device in FDA adverse event reports:

FREMANEZUMAB VFRMHISTAMINE DIHYDROCHLORIDESOMATROPIN

Frequently Asked Questions

Does BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE cause INCORRECT DOSE ADMINISTERED BY DEVICE?

INCORRECT DOSE ADMINISTERED BY DEVICE has been reported as an adverse event in 732 FDA reports for BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is INCORRECT DOSE ADMINISTERED BY DEVICE with BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE?

INCORRECT DOSE ADMINISTERED BY DEVICE accounts for approximately 3.2% of all adverse event reports for BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, making it a notable side effect.

What should I do if I experience INCORRECT DOSE ADMINISTERED BY DEVICE while taking BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE?

If you experience incorrect dose administered by device while taking BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE Full ProfileAll Drugs Causing INCORRECT DOSE ADMINISTERED BY DEVICEAstraZeneca Pharmaceuticals LP Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.